GLP-1 drugmakers are being sued by patients who suddenly lost their vision
Novo Nordisk and Eli Lilly are being sued by patients who say their GLP-1 weight-loss drugs have caused sudden vision loss. The lawsuits claim the patients should have been warned that vision loss was a rare side effect. The pharmaceutical companies say the lawsuits have no merit.
READ NEXT
More on the wire
FROM THE PUBLISHER
Hannah Gann, a white Philly teacher and local activist, admitted that for years she pretended she was Black and Palestinian. She said she deceived racial justice organizers, who called her actions a 'betrayal.'
FROM THE PUBLISHER
Ten people allegedly tied to a Philadelphia drug trafficking operation that shipped in truckloads of cocaine from the Mexican cartel are facing federal charges, the U.S. Attorney's Office says.
FROM THE PUBLISHER
Former Penn Medicine physician executive Joseph Teel has been named president of Trinity Health Mid-Atlantic Medical Group.